Page last updated: 2024-09-04

ro 17-1812 and alprazolam

ro 17-1812 has been researched along with alprazolam in 1 studies

*Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) [MeSH]

*Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) [MeSH]

Compound Research Comparison

Studies
(ro 17-1812)
Trials
(ro 17-1812)
Recent Studies (post-2010)
(ro 17-1812)
Studies
(alprazolam)
Trials
(alprazolam)
Recent Studies (post-2010) (alprazolam)
12101,916591351

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franklin, SR; Tang, AH1

Other Studies

1 other study(ies) available for ro 17-1812 and alprazolam

ArticleYear
The discriminative stimulus effects of diazepam in rats at two training doses.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 258, Issue:3

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Buspirone; Carbolines; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Flumazenil; Male; Morphine; Pentobarbital; Pyrazoles; Pyridazines; Rats; Rats, Inbred Strains; Triazolam

1991